Early insulin for VLBW neonates: little clinical benefit

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1663, 2008-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinol supplementation guidelines for VLBW neonates

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Insulin sensitisers and prompt revascularisation offer little cost benefit

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Fluconazole prophylaxis `safe and effective' in VLBW neonates?

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Clinical pharmacokinetics of phenobarbital in neonates

By Touw D.J. Graafland O. Cranendonk A. Vermeulen R.J. van Weissenbruch M.M.

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 2, 2000-12 ,pp. : 111-116

Elsevier

Access to resources Recommend Favorite

Insulin aspart: promising early results borne out in clinical practice

By Heller Simon Kurtzhals Peter Verge Danilo Lindholm Anders

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 183-195

Informa Healthcare

Access to resources Recommend Favorite